Cadrenal Therapeutics, Inc.
CVKD
$15.50
-$0.775-4.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.19M | -2.41M | -2.39M | -1.66M | -1.14M |
| Total Depreciation and Amortization | 400.00 | 400.00 | 500.00 | 600.00 | 600.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 763.20K | 299.90K | 193.00K | 162.60K | 103.10K |
| Change in Net Operating Assets | 1.63M | -93.70K | 670.30K | -336.30K | 345.90K |
| Cash from Operations | -1.79M | -2.20M | -1.53M | -1.84M | -694.40K |
| Capital Expenditure | -6.50K | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.50K | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 3.62M | 1.53M | 0.00 | 300.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -12.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.84M | -- | -- | -- | -- |
| Cash from Financing | 7.45M | 1.53M | 0.00 | 300.00 | -12.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.65M | -673.30K | -1.53M | -1.84M | -706.90K |